Find out more about PANCAID!
PANCAID video series
In our PANCAID video series, we’ll answer some burning questions about our project.
#1 What is PANCAID?
Join us for an insightful interview with the minds behind PANCAID as they unveil the essence of the project. Meet the project coordinators, discover what PANCAID is and how we aim to propel early detection in pancreatic cancer. Gain insight into the project’s scope, and how it unites experts from various countries and fields. Explore PANCAID’s main output – a minimally invasive blood test to detect pancreatic cancer. Learn from the coordinators about the significance of this approach and how the project aims to achieve it by detecting tumor-related components in the bloodstream through liquid biopsy.
#2 What is Liquid Biopsy?
The biggest challenge in the management of pancreatic cancer is the inability to diagnose it in time. In PANCAID, we focus on the establishment of a blood test for early detection of PDAC via liquid biopsy. But what is liquid biopsy, exactly? Find out in this interview with PANCAID member Prof. Catherine Alix-Panabières, who is professor of cancerology at the University Hospital Center of Montpellier, France, Director of the Laboratory of Rare Human Circulating Cells, and happens to have discovered the concept of liquid biopsy and circulating tumour cells in cancer patients together with Klaus Pantel in 2010.
#3 How are patients involved?
In this insightful interview, we sit down with two representatives from Pancreatic Cancer Europe (PCE), a multi-stakeholder platform dedicated to improving the lives of those affected by pancreatic cancer across Europe. We discuss: 1️⃣ Who is PCE? Learn about PCE’s mission to unite experts and advocates to combat pancreatic cancer. 2️⃣ PCE’s Role in PANCAID: Discover how PCE integrates patient voices into PANCAID’s research. 3️⃣ Ensuring Impact: Explore how PCE is working to ensure PANCAID’s findings benefit those living with pancreatic cancer.
#4 What is pancreatic cancer?
Pancreatic cancer is often labeled a silent killer due to its elusive symptoms and late-stage diagnoses. But groundbreaking advancements in early detection, such as the PANCAID initiative, are offering new hope for patients and healthcare professionals alike. In this video, leading experts discuss the challenges of pancreatic cancer, the potential of liquid biopsies, and how innovative diagnostic tools could revolutionize early detection and treatment.
Topics covered:
- What pancreatic cancer is and why early detection is critical
- Insights into tumor growth and metastasis
- The role of liquid biopsy and blood-based diagnostics
- The vision for the PANAID project and its clinical potential.